Orladeyo European Union - English - EMA (European Medicines Agency)

orladeyo

biocryst ireland limited - berotralstat dihydrochloride - angioedemas, hereditary - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.

BERINERT Israel - English - Ministry of Health

berinert

csl behring ltd., israel - c - 1 esterase inhibitor human - powder for solution for inj/inf - c - 1 esterase inhibitor human 500 iu/vial - c1- inhibitor,plasma derived - c1- inhibitor,plasma derived - hereditary angioedema type i and ii (hae).treatment and pre-procedure (prior to oral, dental, and upper respiratory tract procedures) prevention of acute episodes

Cinryze European Union - English - EMA (European Medicines Agency)

cinryze

takeda manufacturing austria ag - c1 inhibitor (human) - angioedemas, hereditary - c1-inhibitor, plasma derived, drugs used in hereditary angioedema - treatment and pre-procedure prevention of angioedema attacks in adults, adolescents and children (2 years old and above) with hereditary angioedema (hae).routine prevention of angioedema attacks in adults, adolescents and children (6 years old and above) with severe and recurrent attacks of hereditary angioedema (hae), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.

Firazyr European Union - English - EMA (European Medicines Agency)

firazyr

takeda pharmaceuticals international ag - icatibant - angioedemas, hereditary - cardiac therapy - firazyr is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults (with c1-esterase-inhibitor deficiency).

Ruconest European Union - English - EMA (European Medicines Agency)

ruconest

pharming group n.v. - recombinant human c1-inhibitor - angioedemas, hereditary - drugs used in hereditary angioedema, other hematological agents - ruconest is indicated for treatment of acute angioedema attacks in adults with hereditary angioedema (hae) due to c1-esterase-inhibitor deficiency.

CINRYZE POWDER FOR SOLUTION Canada - English - Health Canada

cinryze powder for solution

takeda canada inc - c1 esterase inhibitor (human) - powder for solution - 500unit - c1 esterase inhibitor (human) 500unit - complement inhibitors

FIRAZYR SOLUTION Canada - English - Health Canada

firazyr solution

takeda canada inc - icatibant (icatibant acetate) - solution - 10mg - icatibant (icatibant acetate) 10mg - complement inhibitors

HAEGARDA KIT Canada - English - Health Canada

haegarda kit

csl behring canada inc - c1 esterase inhibitor (human) - kit - 2000unit - c1 esterase inhibitor (human) 2000unit - complement inhibitors

HAEGARDA KIT Canada - English - Health Canada

haegarda kit

csl behring canada inc - c1 esterase inhibitor (human) - kit - 3000unit - c1 esterase inhibitor (human) 3000unit - complement inhibitors

SCOTT-VINCENT BORBA ANTI-FATIGE 8 HOUR MINERAL FOUNDATION WITH BROAD SPECTRUM SPF 29- zinc oxide powder United States - English - NLM (National Library of Medicine)

scott-vincent borba anti-fatige 8 hour mineral foundation with broad spectrum spf 29- zinc oxide powder

scott-vincent borba - zinc oxide 18% - sunscreen - helps prevent sunburn. - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun.